Geode Capital Management’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-573,452
| Closed | -$16.1M | – | 5074 |
|
|
2022
Q1 | $16.1M | Buy |
573,452
+5,138
| +0.9% | +$141K | ﹤0.01% | 2032 |
|
|
2021
Q4 | $15.5M | Buy |
568,314
+1,888
| +0.3% | +$51.2K | ﹤0.01% | 2130 |
|
|
2021
Q3 | $15.4M | Buy |
566,426
+12,023
| +2% | +$297K | ﹤0.01% | 2146 |
|
|
2021
Q2 | $9.47M | Buy |
554,403
+17,936
| +3% | +$336K | ﹤0.01% | 2495 |
|
|
2021
Q1 | $11.2M | Buy |
536,467
+36,679
| +7% | +$846K | ﹤0.01% | 2279 |
|
|
2020
Q4 | $11.4M | Buy |
499,788
+14,613
| +3% | +$278K | ﹤0.01% | 2078 |
|
|
2020
Q3 | $7.91M | Buy |
485,175
+12,556
| +3% | +$227K | ﹤0.01% | 2109 |
|
|
2020
Q2 | $6.4M | Buy |
472,619
+23,273
| +5% | +$271K | ﹤0.01% | 2197 |
|
|
2020
Q1 | $5.32M | Buy |
449,346
+27,822
| +7% | +$617K | ﹤0.01% | 2109 |
|
|
2019
Q4 | $10.5M | Buy |
421,524
+7,594
| +2% | +$154K | ﹤0.01% | 1982 |
|
|
2019
Q3 | $7.04M | Buy |
413,930
+12,541
| +3% | +$228K | ﹤0.01% | 2167 |
|
|
2019
Q2 | $9.13M | Buy |
401,389
+28,317
| +8% | +$764K | ﹤0.01% | 2019 |
|
|
2019
Q1 | $12M | Buy |
373,072
+31,502
| +9% | +$975K | ﹤0.01% | 1773 |
|
|
2018
Q4 | $9.63M | Buy |
341,570
+29,102
| +9% | +$852K | ﹤0.01% | 1809 |
|
|
2018
Q3 | $8.98M | Buy |
312,468
+21,484
| +7% | +$645K | ﹤0.01% | 2008 |
|
|
2018
Q2 | $10.9M | Buy |
290,984
+23,712
| +9% | +$931K | ﹤0.01% | 1806 |
|
|
2018
Q1 | $10.5M | Buy |
267,272
+10,790
| +4% | +$394K | ﹤0.01% | 1729 |
|
|
2017
Q4 | $8.31M | Buy |
256,482
+11,701
| +5% | +$351K | ﹤0.01% | 1872 |
|
|
2017
Q3 | $7.62M | Buy |
244,781
+6,314
| +3% | +$187K | ﹤0.01% | 1936 |
|
|
2017
Q2 | $6.67M | Buy |
238,467
+3,586
| +2% | +$81.2K | ﹤0.01% | 1949 |
|
|
2017
Q1 | $4.03M | Buy |
234,881
+8,417
| +4% | +$118K | ﹤0.01% | 2241 |
|
|
2016
Q4 | $2.74M | Buy |
226,464
+20,494
| +10% | +$265K | ﹤0.01% | 2452 |
|
|
2016
Q3 | $3.26M | Buy |
205,970
+63,918
| +45% | +$963K | ﹤0.01% | 2239 |
|
|
2016
Q2 | $1.84M | Buy |
142,052
+12,959
| +10% | +$203K | ﹤0.01% | 2536 |
|
|
2016
Q1 | $2.45K | Buy |
129,093
+12,240
| +10% | +$222K | ﹤0.01% | 2327 |
|
|
2015
Q4 | $2.63M | Buy |
116,853
+1,460
| +1% | +$28.9K | ﹤0.01% | 2301 |
|
|
2015
Q3 | $2.7M | Buy |
115,393
+5,684
| +5% | +$157K | ﹤0.01% | 2234 |
|
|
2015
Q2 | $3.14M | Buy |
109,709
+73,074
| +199% | +$1.92M | ﹤0.01% | 2219 |
|
|
2015
Q1 | $946K | Buy |
36,635
+7,363
| +25% | +$168K | ﹤0.01% | 2907 |
|
|
2014
Q4 | $542K | Buy |
29,272
+10,967
| +60% | +$197K | ﹤0.01% | 3151 |
|
|
2014
Q3 | $283K | Buy |
+18,305
| New | +$276K | ﹤0.01% | 3432 |
|
Geode Capital Management's XENT Position: Q2 2022 in Review
Geode Capital Management sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 573,452 shares — an estimated $16.1M sold.
Geode Capital Management first reported a position in XENT in Q3 2014 and held it in 31 quarters. The position peaked at $16.1M in Q1 2022. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.
- Geode Capital Management reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
- Geode Capital Management sold 573,452 Intersect ENT, Inc shares in Q2 2022, an estimated $16.1M.
- Geode Capital Management first reported a position in Intersect ENT, Inc in Q3 2014 and held it in 31 quarters.
- Geode Capital Management's Intersect ENT, Inc position peaked at $16.1M in Q1 2022.
- 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.
Based on Geode Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.